73 extractive question-and-answer pairs built from P a R T N E R S, published by icmr.gov.in. Every answer is a verbatim span of text the source prints, and each row carries the passage it sits in, its offset in that passage, the source quote, the page and the location in the document, so any row can be checked against the original. 49 of the 73 pairs (67.1%) are explanatory questions and 24 restate a figure. 97.26% of rows pass the corpus quality gate.
Use the API URL with your free DD token in notebooks, scripts, and pipelines.
https://www.desidata.in/api/datasets/standard-treatment-workflow-for-obstetrics-and-gynecology-question-and-answer/downloadDataset downloads are free. For Python or API downloads, sign in once and create a free DD token; set it as DD_TOKEN or save it in your notebook's secrets. Requests are linked to your account so your download history and counts stay accurate.
# One-time install: pip install desidata
# Set DD_TOKEN in your environment first (create a free token in Profile & settings).
import desidata
df = desidata.load("standard-treatment-workflow-for-obstetrics-and-gynecology-question-and-answer")
df.head()Sign in with Google to download.
Usable for analysis, but expect some cleaning before you rely on it.
Consensus Document on Management of Pancreatic Cancer - Question and Answer Dataset
Economy · 268 rows
ICMR Standard Treatment Workflow for Cataract - Question and Answer Dataset
Economy · 27 rows
Neurology Questions from P a R T N E R S - Question and Answer Dataset
Economy · 107 rows
Beginner's Guide for Systematic Reviews - Question and Answer Dataset
Economy · 407 rows
Annual Report 2015-16 by agriwelfare.gov.in - Question and Answer Dataset
Economy · 1,013 rows
Higher Education in India - Question and Answer Dataset
Economy · 1,594 rows
Gender Policy of NABARD - Question and Answer Dataset
Economy · 14 rows
ICAR Annual Report 2025-26 - Question and Answer Dataset
Economy · 1,101 rows
First 10 of 76 rows
| question | answer | context | answer_start | question_type | knowledge_quality_score | source_quote | source_page | source_location | confidence | validation_status |
|---|---|---|---|---|---|---|---|---|---|---|
| What is the purpose of aortic compression during transport? | to reduce blood loss while awaiting definitive steps | Patient must be transported with I/V fluids containing oxytocin on flow and preferably with uterine/vaginal tamponade in situ. • Aortic compression may be used as a short time measure to reduce blood loss while awaiting definitive steps. • Non- pneumatic anti-shock garment (NASG) should be used during transport if available • Uterine artery embolization may be offered in selected patients if facilities are available If bleeding continues without any apparent cause check for coagulopathy | 184 | definition | 1.000 | • Aortic compression may be used as a short time measure to reduce blood loss while awaiting definitive steps. | 13 | page=13,block=19 | 0.700 | valid |
| What determines the timing and place of the next antenatal care visit? | presence or absence of risk factor | • • Timing and place of next ANC visit based on presence or absence of risk factor • Rest, nutrition, balanced diet and exercise • Counselling for HIV testing • Danger signs ∙ Institutional delivery ∙ Birth preparedness Early & exclusive breastfeeding for six months | 48 | relationship | 0.970 | • • Timing and place of next ANC visit based on presence or absence of risk factor • Rest, nutrition, balanced diet and exercise • Counselling for HIV testing • Danger signs ∙ Institutional delivery ∙ Birth preparedness Early & exclusive breastfeeding for six months | 8 | page=8,block=36 | 0.700 | valid |
| What is the purpose of empowering physicians and surgeons in healthcare? | achieving the overall goal of Universal Health Coverage | To empower the primary, secondary and tertiary care physicians/ surgeons towards achieving the overall goal of Universal Health Coverage with disease management protocols and pre-defined referral mechanisms by decoding complex guidelines | 81 | summary | 0.970 | To empower the primary, secondary and tertiary care physicians/ surgeons towards achieving the overall goal of Universal Health Coverage with disease management protocols and pre-defined referral mechanisms by decoding complex guidelines | 6 | page=6,block=2 | 0.700 | valid |
| What decision regarding the ovaries must be made during a hysterectomy? | Removal/ conservation of ovaries & tubes | ∙ Need for hysterectomy ∙ Alternative treatment options ∙ Risks and benefits ∙ Potential complications of the procedure ∙ Removal/ conservation of ovaries & tubes ∙ Route of hysterectomy ∙ Possible need for post operative Hormone therapy in selected cases ∙ Complete Blood Count • Blood grouping & cross matching ∙ Fasting & Post Prandial Blood Sugar ∙ Renal Function Test ∙ Liver Function Test ∙ Urine Routine & Microscopy ∙ Electrocardiogram ∙ X ray chest ∙ Pre-anesthetic checkup (PAC) | 122 | summary | 0.970 | ∙ Need for hysterectomy ∙ Alternative treatment options ∙ Risks and benefits ∙ Potential complications of the procedure ∙ Removal/ conservation of ovaries & tubes ∙ Route of hysterectomy ∙ Possible need for post operative Hormone therapy in selected cases ∙ Complete Blood Count • Blood grouping & cross matching ∙ Fasting & Post Prandial Blood Sugar ∙ Renal Function Test ∙ Liver Function Test ∙ Urine Routine & Microscopy ∙ Electrocardiogram ∙ X ray chest ∙ Pre-anesthetic checkup (PAC) | 11 | page=11,block=24 | 0.700 | valid |
| What is suggested for pre-menopausal women having a hysterectomy for benign conditions? | it is recommended to combine it with bilateral salpingectomy with a view to minimise the risk of subsequent development of ovarian malignancy | December/ 2025 • Adequate iron and calcium & Vitamin D3 supplements • Ovaries should be preserved in most pre-menopausal women unless diseased or removal specifically indicated • While doing hysterectomy for benign gynaecological conditions in pre-menopausal women, it is recommended to combine it with bilateral salpingectomy with a view to minimise the risk of subsequent development of ovarian malignancy | 266 | summary | 0.970 | December/ 2025 • Adequate iron and calcium & Vitamin D3 supplements • Ovaries should be preserved in most pre-menopausal women unless diseased or removal specifically indicated • While doing hysterectomy for benign gynaecological conditions in pre-menopausal women, it is recommended to combine it with bilateral salpingectomy with a view to minimise the risk of subsequent development of ovarian malignancy | 11 | page=11,block=50 | 0.700 | valid |
| Who created the STW and what factors were considered? | This STW has been prepared by national experts of India with feasibility considerations for various levels of healthcare system in the country | This STW has been prepared by national experts of India with feasibility considerations for various levels of healthcare system in the country. These broad guidelines are advisory, and are based on expert opinions and available scientific evidence. There may be variations in the management of an individual patient based on his/her specific condition, as decided by the treating physician. There will be no indemnity for direct or indirect consequences. Kindly visit the website of ICMR for more information: (icmr.gov.in) for more information. ©Indian Council of Medical Research, Ministry of Health & Family Welfare, Government of India | 0 | summary | 0.970 | This STW has been prepared by national experts of India with feasibility considerations for various levels of healthcare system in the country. | 12 | page=12,block=2 | 0.700 | valid |
| What does the STW indicate about how patient management might vary? | There may be variations in the management of an individual patient based on his/her specific condition, as decided by the treating physician | This STW has been prepared by national experts of India with feasibility considerations for various levels of healthcare system in the country. These broad guidelines are advisory, and are based on expert opinions and available scientific evidence. There may be variations in the management of an individual patient based on his/her specific condition, as decided by the treating physician. There will be no indemnity for direct or indirect consequences. Kindly visit the website of ICMR for more information: (icmr.gov.in) for more information. ©Indian Council of Medical Research, Ministry of Health & Family Welfare, Government of India | 249 | summary | 0.970 | These broad guidelines are advisory, and are based on expert opinions and available scientific evidence. There may be variations in the management of an individual patient based on his/her specific condition, as decided by the treating physician. | 12 | page=12,block=2 | 0.700 | valid |
| What are the first steps taken in primary and secondary care hospitals for addressing gynecological conditions? | Initial Detec- tion and Counselling | Treatment modality should be individualized to each patient after considering patient’s age, parity, severity of symptoms, need for fertility preservation, presence of other gynecological diseases and any other co-morbidity • Primary and secondary Care Hospitals: Initial Detec- tion and Counselling • Symptom Management: Non-Steroidal Anti-Inflamma- tory Drugs (NSAIDs), iron and folic acid • Basic Medical Therapy: oral contraceptives or progestin for abnormal bleeding. • Referral: Cases requiring definitive diagnosis, special- ized treatment, or surgery Tertiary Care Hospitals Advanced Diagnostics: Transvaginal ultrasound, saline infusion sonography, MRI, and hysteroscopy Therapeutic Surgical Interventions: Myomectomy or hysterectomy Minimally Invasive Procedures: Laproscopic or hysteroscopic myomectomy and polypectomy Specialized non-surgical Management: May be considered in specialised situations eg fibroid with subfertility. | 264 | summary | 0.970 | Treatment modality should be individualized to each patient after considering patient’s age, parity, severity of symptoms, need for fertility preservation, presence of other gynecological diseases and any other co-morbidity • Primary and secondary Care Hospitals: Initial Detec- tion and Counselling • Symptom Management: Non-Steroidal Anti-Inflamma- tory Drugs (NSAIDs), iron and folic acid • Basic Medical Therapy: oral contraceptives or progestin for abnormal bleeding. | ||||
| What is the full form of the abbreviation ANC? | Antenatal Care | ANC: Antenatal Care APH: Antepartum Haemorrhage BOH: Bad Obstetrics History CVS: Chorionic Villus Sampling EDD: Estimated Due Date FHS: Foetal Head Station GDM: Gestational Diabetes Mellitus PPH: Post Partum Haemorrhage RCH: Reproductive and Child Health Td: Tetanus Diphtheria TSH: Thyroid Stimulating Hormone UPT: Urine Pregnancy Test USG: Ultrasound Sonography | 5 | definition | 0.940 | ANC: Antenatal Care APH: Antepartum Haemorrhage BOH: Bad Obstetrics History CVS: Chorionic Villus Sampling EDD: Estimated Due Date FHS: Foetal Head Station GDM: Gestational Diabetes Mellitus PPH: Post Partum Haemorrhage RCH: Reproductive and Child Health Td: Tetanus Diphtheria TSH: Thyroid Stimulating Hormone UPT: Urine Pregnancy Test USG: Ultrasound Sonography | 8 | page=8,block=64 | 0.700 | valid |
| What is the full form of the abbreviation PPH? | Post Partum Haemorrhage | ANC: Antenatal Care APH: Antepartum Haemorrhage BOH: Bad Obstetrics History CVS: Chorionic Villus Sampling EDD: Estimated Due Date FHS: Foetal Head Station GDM: Gestational Diabetes Mellitus PPH: Post Partum Haemorrhage RCH: Reproductive and Child Health Td: Tetanus Diphtheria TSH: Thyroid Stimulating Hormone UPT: Urine Pregnancy Test USG: Ultrasound Sonography | 196 | definition | 0.940 | ANC: Antenatal Care APH: Antepartum Haemorrhage BOH: Bad Obstetrics History CVS: Chorionic Villus Sampling EDD: Estimated Due Date FHS: Foetal Head Station GDM: Gestational Diabetes Mellitus PPH: Post Partum Haemorrhage RCH: Reproductive and Child Health Td: Tetanus Diphtheria TSH: Thyroid Stimulating Hormone UPT: Urine Pregnancy Test USG: Ultrasound Sonography | 8 | page=8,block=64 | 0.700 | valid |
Read straight from the file — download or use the API URL for the full dataset.
| 12 |
| page=12,block=6 |
| 0.700 |
| valid |